Mostrar el registro sencillo del ítem

dc.contributor.author
Roque Moreno, Maria  
dc.contributor.author
Vargas Roig, Laura Maria  
dc.contributor.other
Binda, Oliver  
dc.contributor.other
Fernandez Zapico, Martin Ernesto  
dc.date.available
2020-05-22T20:42:19Z  
dc.date.issued
2016  
dc.identifier.citation
Roque Moreno, Maria; Vargas Roig, Laura Maria; Crosstalk between DNA methylation chromatin structure; Elsevier; 2016; 257-270  
dc.identifier.isbn
978-0-12-802389-1  
dc.identifier.uri
http://hdl.handle.net/11336/105832  
dc.description.abstract
Regulation of gene expression is the result of a functional crosstalk between multiple epigenetic pathways. DNA methylation is an epigenetic mark that is typically related to gene silencing. Changes in DNA methylation are associated with specific histone modifications (other members in the crosstalk), including methylation and acetylation in N-terminal tails. Interestingly, these posttranslational histone modifications do not occur at random and are a consequence of the regulated crosstalk with DNA methylation. DNA methylation enzymes direct the histone modification process in a reversible way. Alterations in the crosstalk between DNA and histone modifications can lead to disease, for example, cancer. In the tumorigenic progression, it is proposed that cancer cells may modify their gene expression profile through the accumulation of genetic and epigenetic alterations. These changes affect the pathways that control the cell cycle. At the DNA level, tumors usually present global hypomethylation and tumor suppressor gene hypermethylation. At the histone level, the crosstalk is altered, and mistargeted histone deacetylase activity causes pathological gene silencing. Given the functionally linked crosstalk, the development of drugs that inhibit their interaction would open a promising window for future cancer treatments.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
CANCER  
dc.subject
CHROMATIN STRUCTURE  
dc.subject
CROSSTALK  
dc.subject
DNA METHYLATION  
dc.subject.classification
Otras Ciencias Biológicas  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Crosstalk between DNA methylation chromatin structure  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.type
info:eu-repo/semantics/bookPart  
dc.type
info:ar-repo/semantics/parte de libro  
dc.date.updated
2020-05-11T15:42:49Z  
dc.journal.pagination
257-270  
dc.journal.pais
Estados Unidos  
dc.description.fil
Fil: Roque Moreno, Maria. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina. Universidad Nacional de Cuyo; Argentina  
dc.description.fil
Fil: Vargas Roig, Laura Maria. Universidad Nacional de Cuyo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/B978-0-12-802389-1.00014-9  
dc.conicet.paginas
466  
dc.source.titulo
Chromatin signaling and diseases